Blute ML - Search Results

1

Mononuclear cell infiltration in clear-cell renal cell carcinoma independently predicts patient survival.

Webster WS, Lohse CM, Thompson RH, Dong H, Frigola X, Dicks DL, Sengupta S, Frank I, Leibovich BC, Blute ML, Cheville JC, Kwon ED. Webster WS, et al. Among authors: blute ml. Cancer. 2006 Jul 1;107(1):46-53. doi: 10.1002/cncr.21951. Cancer. 2006. PMID: 16708355 Free article.

2

Transitional cell carcinoma of the renal pelvis: nuclear deoxyribonucleic acid ploidy studied by flow cytometry.

Blute ML, Tsushima K, Farrow GM, Therneau TM, Lieber MM. Blute ML, et al. J Urol. 1988 Nov;140(5):944-9. doi: 10.1016/s0022-5347(17)41894-5. J Urol. 1988. PMID: 3172363

3

Prospective analysis of the incidence of ipsilateral adrenal metastasis in localized renal cell carcinoma.

Kletscher BA, Qian J, Bostwick DG, Blute ML, Zincke H. Kletscher BA, et al. Among authors: blute ml. J Urol. 1996 Jun;155(6):1844-6. J Urol. 1996. PMID: 8618270

4

Disease outcome in patients with low stage renal cell carcinoma treated with nephron sparing or radical surgery.

Lerner SE, Hawkins CA, Blute ML, Grabner A, Wollan PC, Eickholt JT, Zincke H. Lerner SE, et al. Among authors: blute ml. J Urol. 1996 Jun;155(6):1868-73. J Urol. 1996. PMID: 8618276

5

Clinical research priorities in renal cell carcinoma: renal cell carcinoma chemoprevention strategies including target populations, proposed agents, and clinical trial designs--Workgroup No. 6. Union Internationale Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC).

Hanash KA, Aquilina JW, Barrett DM, Blute ML, Cockett AT, Corica FA, Hillman GG, Zbar B, Zhuang Z. Hanash KA, et al. Among authors: blute ml. Cancer. 1997 Sep 1;80(5):999-1001. doi: 10.1002/(sici)1097-0142(19970901)80:5<999::aid-cncr29>3.0.co;2-q. Cancer. 1997. PMID: 9307208 Review. No abstract available.

6

Primary surgical therapy for clinical stage T3 adenocarcinoma of the prostate.

Amling CL, Leibovich BC, Lerner SE, Bergstralh EJ, Blute ML, Myers RP, Zincke H. Amling CL, et al. Among authors: blute ml. Semin Urol Oncol. 1997 Nov;15(4):215-21. Semin Urol Oncol. 1997. PMID: 9421448 Review.

7

Prediction of patient outcome in pathologic stage T2 adenocarcinoma of the prostate: lack of significance for microvessel density analysis.

Gettman MT, Bergstralh EJ, Blute M, Zincke H, Bostwick DG. Gettman MT, et al. Urology. 1998 Jan;51(1):79-85. doi: 10.1016/s0090-4295(97)00464-0. Urology. 1998. PMID: 9457293

8

Pathologic classification of prostate carcinoma: the impact of margin status.

Blute ML, Bostwick DG, Seay TM, Martin SK, Slezak JM, Bergstralh EJ, Zincke H. Blute ML, et al. Cancer. 1998 Mar 1;82(5):902-8. doi: 10.1002/(sici)1097-0142(19980301)82:5<902::aid-cncr15>3.0.co;2-4. Cancer. 1998. PMID: 9486580

9

Prostate specific membrane antigen expression in prostatic intraepithelial neoplasia and adenocarcinoma: a study of 184 cases.

Bostwick DG, Pacelli A, Blute M, Roche P, Murphy GP. Bostwick DG, et al. Cancer. 1998 Jun 1;82(11):2256-61. doi: 10.1002/(sici)1097-0142(19980601)82:11<2256::aid-cncr22>3.0.co;2-s. Cancer. 1998. PMID: 9610707

10

Cancer volume of lymph node metastasis predicts progression in prostate cancer.

Cheng L, Bergstralh EJ, Cheville JC, Slezak J, Corica FA, Zincke H, Blute ML, Bostwick DG. Cheng L, et al. Among authors: blute ml. Am J Surg Pathol. 1998 Dec;22(12):1491-500. doi: 10.1097/00000478-199812000-00006. Am J Surg Pathol. 1998. PMID: 9850175

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

424 results

Search Page